Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase

The first and rate-limiting step of the kynurenine pathway, in which tryptophan (Trp) is converted to N-formylkynurenine is catalyzed by two heme-containing proteins, Indoleamine 2,3-dioxygenase (IDO), and Tryptophan 2,3-dioxygenase (TDO). In mammals, TDO is found exclusively in liver tissue, IDO is...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Capece, L., Arrar, M., Roitberg, A.E., Yeh, S.-R., Marti, M.A., Estrin, D.A.
Formato: JOUR
Materias:
CO
IDO
TDO
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_08873585_v78_n14_p2961_Capece
Aporte de:
id todo:paper_08873585_v78_n14_p2961_Capece
record_format dspace
spelling todo:paper_08873585_v78_n14_p2961_Capece2023-10-03T15:40:51Z Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase Capece, L. Arrar, M. Roitberg, A.E. Yeh, S.-R. Marti, M.A. Estrin, D.A. Affinity CO Dioxygenase IDO Inhibitors Molecular dynamics Oxygen Structure TDO carbon monoxide indoleamine 2,3 dioxygenase oxygen tryptophan 2,3 dioxygenase article enzyme binding enzyme specificity enzyme substrate complex molecular dynamics molecular interaction priority journal protein conformation quantum chemistry stereospecificity Binding Sites Catalysis Humans Indoleamine-Pyrrole 2,3,-Dioxygenase Models, Molecular Molecular Dynamics Simulation Protein Conformation Stereoisomerism Substrate Specificity Tryptophan Tryptophan Oxygenase Mammalia The first and rate-limiting step of the kynurenine pathway, in which tryptophan (Trp) is converted to N-formylkynurenine is catalyzed by two heme-containing proteins, Indoleamine 2,3-dioxygenase (IDO), and Tryptophan 2,3-dioxygenase (TDO). In mammals, TDO is found exclusively in liver tissue, IDO is found ubiquitously in all tissues. IDO has become increasingly popular in pharmaceutical research as it was found to be involved in many physiological situations, including immune escape of cancer. More importantly, small-molecule inhibitors of IDO are currently utilized in cancer therapy. One of the main concerns for the design of human IDO (hIDO) inhibitors is that they should be selective enough to avoid inhibition of TDO. In this work, we have used a combination of classical molecular dynamics (MD) and hybrid quantum-classical (QM/MM) methodologies to establish the structural basis that determine the differences in (a) the interactions of TDO and IDO with small ligands (CO/O 2) and (b) the substrate stereo-specificity in hIDO and TDO. Our results indicate that the differences in small ligand bound structures of IDO and TDO arise from slight differences in the structure of the bound substrate complex. The results also show that substrate stereospecificity of TDO is achieved by the perfect fit of L-Trp, but not D-Trp, which exhibits weaker interactions with the protein matrix. For hIDO, the presence of multiple stable binding conformations for L/D-Trp reveal the existence of a large and dynamic active site. Taken together, our data allow determination of key interactions useful for the future design of more potent hIDO-selective inhibitors. © 2010 Wiley-Liss, Inc. Fil:Capece, L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Marti, M.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Estrin, D.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_08873585_v78_n14_p2961_Capece
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Affinity
CO
Dioxygenase
IDO
Inhibitors
Molecular dynamics
Oxygen
Structure
TDO
carbon monoxide
indoleamine 2,3 dioxygenase
oxygen
tryptophan 2,3 dioxygenase
article
enzyme binding
enzyme specificity
enzyme substrate complex
molecular dynamics
molecular interaction
priority journal
protein conformation
quantum chemistry
stereospecificity
Binding Sites
Catalysis
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase
Models, Molecular
Molecular Dynamics Simulation
Protein Conformation
Stereoisomerism
Substrate Specificity
Tryptophan
Tryptophan Oxygenase
Mammalia
spellingShingle Affinity
CO
Dioxygenase
IDO
Inhibitors
Molecular dynamics
Oxygen
Structure
TDO
carbon monoxide
indoleamine 2,3 dioxygenase
oxygen
tryptophan 2,3 dioxygenase
article
enzyme binding
enzyme specificity
enzyme substrate complex
molecular dynamics
molecular interaction
priority journal
protein conformation
quantum chemistry
stereospecificity
Binding Sites
Catalysis
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase
Models, Molecular
Molecular Dynamics Simulation
Protein Conformation
Stereoisomerism
Substrate Specificity
Tryptophan
Tryptophan Oxygenase
Mammalia
Capece, L.
Arrar, M.
Roitberg, A.E.
Yeh, S.-R.
Marti, M.A.
Estrin, D.A.
Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase
topic_facet Affinity
CO
Dioxygenase
IDO
Inhibitors
Molecular dynamics
Oxygen
Structure
TDO
carbon monoxide
indoleamine 2,3 dioxygenase
oxygen
tryptophan 2,3 dioxygenase
article
enzyme binding
enzyme specificity
enzyme substrate complex
molecular dynamics
molecular interaction
priority journal
protein conformation
quantum chemistry
stereospecificity
Binding Sites
Catalysis
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase
Models, Molecular
Molecular Dynamics Simulation
Protein Conformation
Stereoisomerism
Substrate Specificity
Tryptophan
Tryptophan Oxygenase
Mammalia
description The first and rate-limiting step of the kynurenine pathway, in which tryptophan (Trp) is converted to N-formylkynurenine is catalyzed by two heme-containing proteins, Indoleamine 2,3-dioxygenase (IDO), and Tryptophan 2,3-dioxygenase (TDO). In mammals, TDO is found exclusively in liver tissue, IDO is found ubiquitously in all tissues. IDO has become increasingly popular in pharmaceutical research as it was found to be involved in many physiological situations, including immune escape of cancer. More importantly, small-molecule inhibitors of IDO are currently utilized in cancer therapy. One of the main concerns for the design of human IDO (hIDO) inhibitors is that they should be selective enough to avoid inhibition of TDO. In this work, we have used a combination of classical molecular dynamics (MD) and hybrid quantum-classical (QM/MM) methodologies to establish the structural basis that determine the differences in (a) the interactions of TDO and IDO with small ligands (CO/O 2) and (b) the substrate stereo-specificity in hIDO and TDO. Our results indicate that the differences in small ligand bound structures of IDO and TDO arise from slight differences in the structure of the bound substrate complex. The results also show that substrate stereospecificity of TDO is achieved by the perfect fit of L-Trp, but not D-Trp, which exhibits weaker interactions with the protein matrix. For hIDO, the presence of multiple stable binding conformations for L/D-Trp reveal the existence of a large and dynamic active site. Taken together, our data allow determination of key interactions useful for the future design of more potent hIDO-selective inhibitors. © 2010 Wiley-Liss, Inc.
format JOUR
author Capece, L.
Arrar, M.
Roitberg, A.E.
Yeh, S.-R.
Marti, M.A.
Estrin, D.A.
author_facet Capece, L.
Arrar, M.
Roitberg, A.E.
Yeh, S.-R.
Marti, M.A.
Estrin, D.A.
author_sort Capece, L.
title Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase
title_short Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase
title_full Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase
title_fullStr Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase
title_full_unstemmed Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase
title_sort substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase
url http://hdl.handle.net/20.500.12110/paper_08873585_v78_n14_p2961_Capece
work_keys_str_mv AT capecel substratestereospecificityintryptophandioxygenaseandindoleamine23dioxygenase
AT arrarm substratestereospecificityintryptophandioxygenaseandindoleamine23dioxygenase
AT roitbergae substratestereospecificityintryptophandioxygenaseandindoleamine23dioxygenase
AT yehsr substratestereospecificityintryptophandioxygenaseandindoleamine23dioxygenase
AT martima substratestereospecificityintryptophandioxygenaseandindoleamine23dioxygenase
AT estrinda substratestereospecificityintryptophandioxygenaseandindoleamine23dioxygenase
_version_ 1782025362296799232